Adi D. Sabag

411 total citations
19 papers, 321 citations indexed

About

Adi D. Sabag is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Adi D. Sabag has authored 19 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Adi D. Sabag's work include Axon Guidance and Neuronal Signaling (10 papers), Angiogenesis and VEGF in Cancer (7 papers) and Multiple Myeloma Research and Treatments (2 papers). Adi D. Sabag is often cited by papers focused on Axon Guidance and Neuronal Signaling (10 papers), Angiogenesis and VEGF in Cancer (7 papers) and Multiple Myeloma Research and Treatments (2 papers). Adi D. Sabag collaborates with scholars based in Israel, Germany and United Kingdom. Adi D. Sabag's co-authors include Gera Neufeld, Ofra Kessler, Zahava Vadasz, Karen B. Avraham, Wilfried Kugler, Boaz Kigel, Julia Bode, Or Dagan, Jacob Bejar and Marius Ueffing and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Adi D. Sabag

18 papers receiving 315 citations

Peers

Adi D. Sabag

CMN

IMMUN

PHARM

Simona Bussini Italy

Carolina Uggenti United Kingdom

Nicole H. Wilson Switzerland

Christine Jack United States

Ryosuke Midorikawa Japan

L. Douglas United Kingdom

Cécile Charrière‐Bertrand France

M. Jose Pérez‐García Spain

Hirotada Fujita Japan

Changlin Dou China

Simona Bussini Italy

Adi D. Sabag

180 ×0.9

CMN

172 ×0.9

121 ×2.3

49 ×1.0

IMMUN

10 ×0.3

PHARM

Citations per year, relative to Adi D. Sabag Adi D. Sabag (= 1×) peers Simona Bussini

Countries citing papers authored by Adi D. Sabag

Since Specialization

Citations

This map shows the geographic impact of Adi D. Sabag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi D. Sabag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi D. Sabag more than expected).

Fields of papers citing papers by Adi D. Sabag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi D. Sabag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi D. Sabag. The network helps show where Adi D. Sabag may publish in the future.

Co-authorship network of co-authors of Adi D. Sabag

This figure shows the co-authorship network connecting the top 25 collaborators of Adi D. Sabag. A scholar is included among the top collaborators of Adi D. Sabag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adi D. Sabag. Adi D. Sabag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sabag, Adi D., et al.. (2025). Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis. International Journal of Molecular Sciences. 26(22). 11160–11160.

Sabag, Adi D., et al.. (2024). Soluble CD72, is a T-cell activator probably via binding to CD6 in homeostasis and autoimmunity. Frontiers in Immunology. 15. 1367120–1367120. 3 indexed citations

Tadmor, Tamar, et al.. (2023). The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma. International Journal of Molecular Sciences. 25(1). 549–549. 1 indexed citations

Toledano, Shira, et al.. (2023). Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cells. Cell Death and Disease. 14(1). 41–41. 7 indexed citations

Kessler, Ofra, et al.. (2023). Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases. Frontiers in Pharmacology. 13. 1085892–1085892. 4 indexed citations

Sabag, Adi D., et al.. (2022). CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus. Journal of Autoimmunity. 134. 102960–102960. 7 indexed citations

Veiga‐da‐Cunha, Maria, et al.. (2022). Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients. Frontiers in Pediatrics. 10. 1071464–1071464. 17 indexed citations

Tadmor, Tamar, Adi D. Sabag, Ilana Levy, et al.. (2022). The Involvement of LAG3+ Plasma Cells in the Development of Multiple Myeloma. Blood. 140(Supplement 1). 7112–7113. 2 indexed citations

Rimar, Doron, Merav Lidar, Adi D. Sabag, et al.. (2021). Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria. Inflammation. 45(2). 603–609. 4 indexed citations

10.

Sabag, Adi D., et al.. (2021). The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A. Biomolecules. 11(3). 373–373. 5 indexed citations

11.

Itchaki, Gilad, Lior Rokach, Ohad Benjamini, et al.. (2021). Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia. Blood. 138(Supplement 1). 638–638. 3 indexed citations

12.

Sabag, Adi D., Jacob Bejar, Shira Toledano, et al.. (2019). Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma. Frontiers in Immunology. 10. 550–550. 26 indexed citations

13.

Sabag, Adi D., et al.. (2018). Altered expression of regulatory molecules in the skin of psoriasis. Immunologic Research. 66(6). 649–654. 8 indexed citations

14.

Bejar, Jacob, Ofra Kessler, Adi D. Sabag, et al.. (2018). Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis. Frontiers in Immunology. 9. 634–634. 15 indexed citations

15.

Sabag, Adi D., Yelena Mumblat, Marius Ueffing, et al.. (2014). The role of the plexin-A2 receptor in semaphorin-3A and semaphorin-3B signal transduction. Journal of Cell Science. 127(Pt 24). 5240–52. 33 indexed citations

16.

Sabag, Adi D., et al.. (2012). Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain. PLoS ONE. 7(8). e42912–e42912. 58 indexed citations

17.

Neufeld, Gera, et al.. (2011). Semaphorins in Angiogenesis and Tumor Progression. Cold Spring Harbor Perspectives in Medicine. 2(1). a006718–a006718. 89 indexed citations

18.

Fleishman, Sarel J., Adi D. Sabag, Eran Ophir, Karen B. Avraham, & Nir Ben‐Tal. (2006). The Structural Context of Disease-causing Mutations in Gap Junctions. Journal of Biological Chemistry. 281(39). 28958–28963. 12 indexed citations

19.

Sabag, Adi D., Or Dagan, & Karen B. Avraham. (2005). Connexins in Hearing Loss: A Comprehensive Overview. Journal of Basic and Clinical Physiology and Pharmacology. 16(2-3). 101–116. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact